Dr. Sjakon G Tahija, SpM Vitreoretinal Surgeon

Dr. Sjakon G Tahija, SpM
Vitreoretinal Surgeon
Setelah menyelesaikan fellowship retina di Lions Eye Institute, Perth Australia tahun 1994, Dr Tahija
kembali ke Indonesia dan bekerja sebagai Konsultan Vitreoretina di Jakarta Eye Center sebelum
akhirnya mendirikan jaringan klinik sendiri yaitu Klinik Mata Nusantara pada tahun 2004.
Pendidikan:
• Dokter Spesialis Mata: Fakultas Kedokteran Universitas Indonesia, Jakarta, 1988
Fellowship:
• Vitreoretinal Fellowship, Lions Eye Institute, Perth Australia, 1993 - 1994
• Research Fellowship, University of Wisconsin, Madison, USA, 1988 - 1990
Organisasi Profesi:
• American Academy of Ophthalmology (AAO)
• American Society of Retina Specialists (ASRS)
• Persatuan Dokter Spesialis Mata Indonesia (PERDAMI)
Bidang Pelayanan:
• Vitreoretina
• Katarak
Journal / Publikasi terakhir yang dihasilkan:
Tahija SG, Hersetyati R, Lam GC, Kusaka S, McMenamin PG. Fluorescein angiographic observations of
peripheral retinal vessel growth in infants after intravitreal injection of bevacizumab as sole therapy
for zone I and posterior zone II retinopathy of prematurity. Br J Ophthalmol. 2014; 98:507-512.
Sjakon G Tahija, MD
Vitreoretinal Surgeon
After completing his retinal fellowship at Lions Eye Institute, Perth, Australia in 1994, Dr. Tahija
returned to Indonesia and practiced as a Vitreoretinal Consultant at Jakarta Eye Center before
establishing his own chain of ophthalmology clinics, Klinik Mata Nusantara, in 2004.
Education:
 Ophthalmology residency: University of Indonesia Medical School, Jakarta, 1988
Fellowships:
 Vitreoretinal Fellowship, Lions Eye Institute, Perth, Australia, 1993 - 1994
 Research Fellowship, University of Wisconsin, Madison, USA, 1988 - 1990
Professional Organizations:
 American Academy of Ophthalmology (AAO)
 American Society of Retina Specialists (ASRS)
 Indonesian Ophthalmologists Association (IOA)
Practice Areas:
 Vitreoretina
 Cataract
Latest Publication:
Tahija SG, Hersetyati R, Lam GC, Kusaka S, McMenamin PG. Fluorescein angiographic observations of
peripheral retinal vessel growth in infants after intravitreal injection of bevacizumab as sole therapy
for zone I and posterior zone II retinopathy of prematurity. Br J Ophthalmol. 2014; 98:507-512.